Results: 1-8 |
Results: 8

Authors: Jeremias, I Reinhardt, D Debatin, KM
Citation: I. Jeremias et al., Dysregulation of apoptosis as the basis of disease, HNO, 49(8), 2001, pp. 673-683

Authors: Jeremias, I Reinhardt, D Debatin, KM
Citation: I. Jeremias et al., Irregular apoptosis as basis of disease, MONATS KIND, 148(8), 2000, pp. 795-804

Authors: Jeremias, I Kupatt, C Martin-Villalba, A Habazettl, H Schenkel, J Boekstegers, P Debatin, KM
Citation: I. Jeremias et al., Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia, CIRCULATION, 102(8), 2000, pp. 915-920

Authors: Herr, I Wilhelm, D Meyer, E Jeremias, I Angel, P Debatin, KM
Citation: I. Herr et al., JNK/SAPK activity contributes to TRAIL-induced apoptosis, CELL DEAT D, 6(2), 1999, pp. 130-135

Authors: Fulda, S Jeremias, I Pietsch, T Debatin, KM
Citation: S. Fulda et al., Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors, KLIN PADIAT, 211(4), 1999, pp. 319-322

Authors: Martin-Villalba, A Herr, I Jeremias, I Hahne, M Brandt, R Vogel, J Schenkel, J Herdegen, T Debatin, KM
Citation: A. Martin-villalba et al., CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons, J NEUROSC, 19(10), 1999, pp. 3809-3817

Authors: Fulda, S Jeremias, I Steiner, HH Pietsch, T Debatin, KM
Citation: S. Fulda et al., Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells, INT J CANC, 82(3), 1999, pp. 435-441

Authors: Jeremias, I Debatin, KM
Citation: I. Jeremias et Km. Debatin, TRAIL induces apoptosis and activation of NF kappa B, EUR CYTOKIN, 9(4), 1998, pp. 687-688
Risultati: 1-8 |